Sinopharm
1099.HK
#1965
Rank
$8.33 B
Marketcap
$2.67
Share price
1.22%
Change (1 day)
9.98%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Revenue for Sinopharm (1099.HK)

Revenue in 2023 (TTM): $61.71 Billion USD

According to Sinopharm's latest financial reports the company's current revenue (TTM ) is $80.05 Billion USD. In 2022 the company made a revenue of $80.05 Billion USD a decrease over the revenue in the year 2021 that were of $81.77 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sinopharm from 2006 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) $61.71 B-22.91%
2022 $80.05 B-2.1%
2021$81.77 B16.85%
2020$69.97 B14.95%
2019$60.87 B21.52%
2018$50.09 B5.93%
2017$47.29 B27.22%
2016$37.17 B5.37%
2015$35.27 B9.14%
2014$32.32 B17.22%
2013$27.57 B25.94%
2012$21.89 B34.61%
2011$16.26 B55.34%
2010$10.47 B35.79%
2009$7.71 B37.56%
2008$5.60 B31.43%
2007$4.26 B40.26%
2006$3.04 B